Clinical Trial Update: A Double-blind Study of Controlled Release OROS Hydromorphone Compared to Placebo in Patients With Chronic Osteoarthritis (OA) Pain [Phase 3]

View source ↗

Summary

Phase 3 double-blind trial evaluating controlled release OROS hydromorphone versus placebo in chronic osteoarthritis pain; trial completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Hydromorphone (hydromorphone)

Snippet

Sponsor: Mallinckrodt | Conditions: Chronic Pain | Phase 3 | Status: COMPLETED | Results posted: 2020-08-26